´
P. J. Boratynski et al. / Tetrahedron: Asymmetry 23 (2012) 876–883
882
1.24–1.56 (m, 4H). 13C NMR (300 MHz, CDCl3): d 151.0, 149.9,
149.1, 145.7, 142.2, 130.3, 128.6, 128.4, 127.7, 127.1, 126.4,
126.2, 125.7, 120.1, 114.6, 80.0, 61.2, 57.6, 43.7, 40.1, 28.3, 27.9,
24.9. HR-MS (ESI): calcd for [C25H26N2O+H]+ 371.2118, found:
371.2124.
121.5, 117.5, 114.6, 106.3, 78.4, 63.1, 55.3, 50.8, 48.8, 39.6, 29.4,
26.4, 24.4. IR (KBr): 3302, 2916, 2867, 1623, 1509, 1449, 1240,
1228, 1034, 998, 912, 841, 709 cmꢂ1. HR-MS (ESI): calcd for
[C26H28N2O2+H]+ 401.2224, found: 401.2235.
4.3.2. (9S)-Deoxy-9-phenylquinidine, (8R,9S)-60-methoxy-9-
phenyl-cinchonane 13
4.2.5. 9-Methylquinidine, (8R,9S)-60-methoxy-9-methyl-9-
cinchonanol 2
Off-white solidified oil. 1H NMR (300 MHz, CDCl3): d 8.79 (d,
J = 4.7 Hz, 1H), 7.94 (d, J = 9.3 Hz, 1H), 7.51 (d, J = 4.7 Hz, 1H),
7.38 (d, J = 2.6 Hz, 1H), 7.18–7.35 (m, 5H), 7.10–7.17 (m, 1H),
6.01 (ddd, J = 17.3, 10.6, 17.8 Hz, 1H), 5.06–5.16 (m, 2H), 4.65 (d,
J = 11.2 Hz, 1H), 3.89 (s, 3H), 3.64 (m, 1H), 2.75–3.13 (m, 4H),
2.25 (m, 1H), 1.76 (m, 1H), 1.48–1.70 (m, 3H), 1.13–1.28 (m, 1H).
13C NMR (300 MHz, CDCl3): d 157.5, 147.8, 147.2, 144.9, 140.83,
140.75, 131.9, 129.0, 128.69, 128.66, 127.0, 120.7, 119.5, 114.6,
102.2, 58.1, 55.5, 49.35, 49.34, 47.6, 39.8, 28.1, 27.2, 26.6. HR-MS
(ESI): calcd for [C26H28N2O+H]+ 385.2274 found 385.2281.
The reaction was carried out according to Woodward0s proce-
dure.5 From quinidinone 1 (440 mg, 1.37 mmol) and methylmag-
nesium chloride (3.0 mL, 3 M in Et2O, 9.0 mmol, 6.5 equiv)
280 mg (55%) of 2 were obtained.
Dihydrate ½a 2D3
ꢁ
¼ þ151 (c 0.49, EtOH, 96%); anhydrous lit.5
[a]
D = +168, = +170 (c 0.5, EtOH, 96%). 1H NMR (600 MHz, CDCl3):
d 8.70 (d, J = 4.7 Hz, 1H), 8.03 (d, J = 9.3 Hz, 1H), 7.71 (br, 1H),
7.67 (br, 1H), 7.34 (dd, J = 9.3, 2.5 Hz, 1H), 5.73 (ddd, J = 17.3,
10.5, 7.7 Hz, 1H), 4.87 (d, J = 10.5 Hz, 1H), 4.79 (d, J = 17.3 Hz,
1H), 3.92 (s, 3H), ꢃ3.4 (br, 1H), 3.28 (t, J = 9.1 Hz, 1H), 3.09 (m,
1H), 3.01 (m, 1H), 2.79–2.90 (m, 2H), 2.13 (m, 1H), 1.95 (s, 3H),
1.78 (m, 1H), 1.67 (m, 1H), 1.51–1.56 (m, 2H), 1.01 (m, 1H). 1H
4.4. Autoxidation of 9-deoxy-9-phenyl-quinine
According to the procedure for autoxidation of 8, (9S)-phenyl-9-
deoxy-quinine3 10 (52.5 mg, 0.13 mmol) and sodium dimsylate
obtained from 63 mg of sodium hydride (1.6 mmol, 12 equiv) gave
(9R)-phenyl-quinine 11 (7.2 mg, 13%) and (9S)-phenyl-quinine 12
(4.5 mg, 9%).
NMR (600 MHz, C6D6):
d 8.74 (d, J = 4.6 Hz, 1H), 8.33 (d,
J = 9.1 Hz, 1H), 7.87 (br, 1H), 7.47 (br, 1H), 7.22 (dd, J = 9.1,
2.7 Hz, 1H), 5.92 (m, 1H), 4.95 (d, J = 10.5 Hz, 1H), 4.91 (d,
J = 17.4 Hz, 1H), 3.45 (s, 3H), 3.36 (m, 1H), 3.18 (br, 1H), ꢃ3.0 (br,
1H), 2.79 (m, 1H), 2.74 (dd, J = 13.6, 10.3 Hz, 1H), 2.60 (m, 1H),
1.92 (m, 1H), 1.81–1.88 (m, 1H) 1.86 (s, 3H), 1.42 (m, 1H), 1.12–
1.16 (m, 2H), 0.71 (m, 1H). 13C NMR (150 MHz, CDCl3): d 156.8,
150.9, 147.5, 145.3, 140.3, 132.1, 127.0, 120.6, 119.9, 114.3,
104.3, ꢃ77.3, 63.4, 55.4, 51.2, 41.8, 39.9, 29.6, 28.8, 26.3, 22.1.
4.4.1. 9-Phenylquinine, (8S,9R)-60-methoxy-9-phenyl-9-cinch-
onanol 11
White crystalline solid. Rf (CHCl3/MeOH, 4:1) 0.377, ½a D26
¼ ꢂ27
ꢁ
(c 0.4 EtOH, 96%), ½a D20
ꢁ
¼ ꢂ9:1 (c 1 CH2Cl2), 1H NMR (300 MHz,
CDCl3) d 8.81 (d, J = 4.7 Hz, 1H), 8.02 (br, 1H), 7.93 (d, J = 9.2 Hz,
1H), 7.44–7.48 (m, 2H), 7.19–7.33 (m, 3H), 7.16 (dd, J = 9.2,
2.8 Hz, 1H), 6.81 (br, 1H), 5.92 (ddd, J = 17.2, 10.5, 6.5 Hz, 1H),
5.11 (dt, J = 17.2, 1.8 Hz, 1H), 5.08 (dt, J = 10.5, 1.8 Hz, 1H), 4.04
(m, 1H), 3.48 (s, 3H), 3.10–3.24 (m, 3H), 2.55–2.68 (m, 1H), 2.35
(m, 1H), 2.1–3.8 (br, 1H), 1.82 (m, 1H), 1.19–1.67 (m, 4H). 13C
NMR (75.5 MHz, CDCl3) d 156.5, 149.4, 147.4, 145.7, 145.3, 142.2,
131.5, 128.5, 127.5, 126.9, 121.3, 120.4, 114.7, 104.8, 79.7, 61.1,
57.6, 55.3, 43.6, 39.9, 28.3, 27.8, 25.1, (1 signal overlap). IR (KBr):
3138, 2920, 2859, 1621, 1509, 1449, 1244, 1229, 1032, 837,
4.3. Autoxidation of 9-deoxy-9-phenyl-quinidine 8
Sodium hydride (60% dispersion in oil, 137 mg, 3.45 mmol,
8.8 equiv) was washed with hexane in an N2-filled glovebag, sus-
pended in dry DMSO (1.5 mL), stirred at 75 °C for 1.5 h, and cooled
to room temperature. Then a solution of (9R)-deoxy-9-phenylalka-
loid3 7 (151.6 mg, 0.39 mmol) in DMSO (1.5 mL) was added and the
mixture turned dark red. After stirring for 20 min, dry oxygen was
slowly passed through a solution for 48 h. The mixture initially
warmed up and a gradual discoloration occurred. Then a solution
of sodium hydrogen sulfite in water (1 mL, 40%) was added and
the mixture was agitated for 30 min, and then alkalized with aque-
ous sodium hydroxide (10%) solution. The mixture was then ex-
tracted with ethyl acetate (6 ꢄ 15 mL). The combined organic
phases were washed with brine and dried over Na2SO4 giving after
evaporation approximately 100 mg of residue. Column chromatog-
raphy on silica gel with CHCl3/MeOH 10:1 afforded a mixture con-
taining 9-epi-phenyl-alkaloid 9, followed by pure (9S)-phenyl-
quinidine 4 (32.2 mg, 21%). The epi-alkaloid fraction (ꢃ60 mg)
was again chromatographed on silica gel with CHCl3/MeOH 20:1
and gave pure (9R)-phenyl-quinidine 9 (14.5 mg, 9%) and (9S)-9-
deoxy-9-phenylquinidine 13 (18.4 mg, 12%).
707 cmꢂ1 HR-MS (ESI): calcd for [C26H28N2O2+H]+ 401.2224,
.
found: 401.2234.
4.4.2. epi-9-Phenylquinine, (8S,9S)-60-methoxy-9-phenyl-9-
cinchonanol 12
White crystalline solid. Rf (CHCl3/MeOH, 4:1) 0.450. ½a D23
¼ þ13
ꢁ
(c 0.2 EtOH, 96%). 1H NMR (300 MHz, CDCl3): d 8.77 (d, J = 4.7 Hz,
1H), 7.87 (d, J = 9.2 Hz, 1H), 7.55 (d, J = 2.8 Hz, 1H), 7.31–7.43 (m,
3H), 7.10–7.26 (m, 4H), 6.08 (ddd, J = 17.2, 10.6, 6.6 Hz, 1H), 5.19
(dt, J = 10.6, 1.5 Hz, 1H), 5.17 (dt, J = 17.2, 1.5 Hz, 1H), 3.73 (t,
J = 9.4 Hz, 1H), 3.61 (s, 3H), 3.13 (dd, J = 13.5, 9.9 Hz, 1H), 2.96–
3.04 (m, 1H), 2.81–2.93 (m, 1H), 2.37 (m, 1H), 2.02–2.14 (m, 1H)
1.93 (m, 1H) 1.63–1.73 (m, 1H), 1.13–1.37 (m, 3H). 13C NMR
(75.5 MHz, CDCl3): d 156.8, 150.0, 147.1, 146.1, 143.9, 141.9,
131.2, 128.8, 127.7, 127.6, 127.0, 121.5, 117.6, 115.0, 106.3, 78.9,
62.8, 57.5, 55.4, 43.1, 39.8, 28.4, 27.5, 25.3. IR (KBr): 3296, 2922,
2861, 1621, 1508, 1240, 1224, 1035, 839, 709, 701 cmꢂ1. HR-MS
(ESI): calcd for [C26H28N2O2+H]+ 401.2224, found: 401.2233.
4.3.1. epi-9-Phenylquinidine, (8R,9R)-60-methoxy-9-phenyl-9-
cinchonanol 9
White crystalline solid. Rf (CHCl3/MeOH, 4:1) 0.309.
½
a 2D4
ꢁ
¼ þ110 (c 0.3 EtOH, 96%). 1H NMR (300 MHz, CDCl3): d 8.76
(d, J = 4.7 Hz, 1H), 7.87 (d, J = 9.2 Hz, 1H), 7.59 (d, J = 2.8 Hz, 1H),
7.46 (d, J = 4.6 Hz, 1H), 7.42 (br d, J = ꢃ6.9 Hz, 2H), 7.17–7.27 (m,
3H), 7.15 (dd, J = 9.2, 2.8 Hz, 1H), 5.18 (ddd, J = 17.3, 10.4, 7.0,
1H), 4.71 (d, J = 10.4 Hz, 1H), 4.49 (d, J = 17.3 Hz, 1H), 3.68 (m,
1H), 3.61 (s, 3H), 3.08 (m, 1H), 2.78–2.91 (m, 1H), 2.67 (dd,
J = 13.6, 9.8 Hz, 1H), 2.50–2.60 (m, 1H), 2.09 (q, J = 8.2 Hz, 1H)
1.59–2.01 (m, 5H). 13C NMR (75.5 MHz, CDCl3): d 156.7, 149.8,
146.8, 146.1, 144.0, 139.1, 131.0, 127.64, 127.59, 127.52, 127.0,
Acknowledgements
We are grateful to the Polish Ministry of Science and Higher
Education for financial support; Grant N N204 161036. We would
like to thank Wroclaw Networking and Supercomputing Center
for the allotment of computer time.